Table 1 Demographic Characteristics of the sample.

From: Dynamic respiratory muscle function in late-onset Pompe disease

Ā 

Age (years)

Gender

BMI (kg/cm2)

FVC pred (%)

FEV1 Pred (%)

PIMAX (cmH2O)

PEMAX (cmH2O)

ETCO2 (mm Hg)

VE (L/min)

Age at Diagnosis (years)

Use of ERT

Nighttime Support?

Ā 

Pompe Subjects

P1

50

F

27.12

69.7

69

49

62

34

9.7

42

yes

NO

P2

47

F

25.4

67

66.2

69

79

45

9.9

37

yes

CPAP

P3

52

M

26.4

36.7

35.9

36

88

48

10.2

40

no

BiPAP

P4

32

M

26.58

70.8

73.9

85

139

41

12.1

30

yes

NO

P5

32

F

25.08

95

86.6

79

67

38

12.7

32

no

NO

P6

29

F

16.22

29.2

31.1

36

46

48

10.4

25

yes

BiPAP

P7

63

F

21.48

51.4

60.5

56

59

44

12.5

59

yes

BiPAP

Average

43.6 (±12.8)

Ā 

24.0 (±3.9)

60.0 (±22.6)

60.5 (±20.2)

58.6 (±19.8)

77.1 (±30.5)

42.6 (±5.2)

11.1 (±1.3)

37.8 (±11.0)

Ā Ā 
Ā 

Control Subjects

C1

55

F

35.47

99.7

109.6

83

125

45

7.3

—

—

—

C2

49

F

24.86

133.2

119.6

118

116

41

9.1

—

—

—

C3

53

M

32.09

75

77.9

61

100

40

11.7

—

—

—

C4

29

M

26.18

141.6

106.5

156

115

39

11.1

—

—

—

C5

31

F

22.72

112.5

121

78

96

40

9.7

—

—

—

C6

20

F

23.32

117.7

121

88

102

37

10.4

—

—

—

C7

61

F

23.16

95.3

102.9

83

125

36

7.2

—

—

—

Average

42.6 (±15.7)

Ā 

26.8 (±5.0)

110.7 (±22.9)

108.4 (±15.3)

95.3 (±31.7)

111.3 (±12.0)

39.7 (±2.9)

9.5 (±1.8)

—

—

—

  1. BiPAP: bi-level positive airway pressure; BMI: body mass index; CPAP: continuous positive airway pressure; ERT: enzyme replacement therapy; ETCO2: end-tidal carbon dioxide; FEV1: forced expiratory volume in first second; FVC: forced vital capacity; PIMAX: maximal inspiratory pressure; PEMAX: maximal expiratory pressure; VE: minute ventilation.